Skip to main content
Premium Trial:

Request an Annual Quote

InforSense, Ingenuity Announce Pathway-Analysis Alliance

NEW YORK (GenomeWeb News) — InforSense and Ingenuity today said that customers who have licensed InforSense’s KDE platform and Igenuity’s IPA pathways-analysis software will be able to use newly developed IPA nodes along with their existing KDE workflows.

InforSense said this will enable customers to “enhance and expand” IPA functions and allow them to view genetic information taken from a KDE workflow.

Ingenuity Systems has also joined the InforSense Open Workflow Partner Network.

The IPA nodes are available through InforSense, the company said.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.